RELATED STORIES

Enrollment Modeling Results in Productivity Gains for Merck | Aug 01, 2011
Embracing Adaptive Designs at Merck | Jan 21, 2011
Life Scientists Get Their Game Faces On | Mar 26, 2008
Entelos’ First Year as a Public Company | May 11, 2007
Leading by Example | Mar 09, 2007
Resolute in the New Year | Dec 20, 2006
Merck President Touts Technology Benefits | Mar 01, 2006
Wanted: Tough Computational Problems | Jun 13, 2005

Merck Faces Another Tough Year

Dec. 3, 2008 | Has Merck's comeback turned into a wipeout? Forbes.

Click here to login and leave a comment.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

RELATED
RESOURCES & PRODUCTS

The US Drug Approval Trends and Yearbook 2008/2009

2 Year - U.S. Regulatory Reporter Newsletter for International Addresses Outside of Europe

2 Year - U.S. Regulatory Reporter Newsletter for Addresses in Europe

For reprints and/or copyright permission, please contact Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.

250 First Avenue Suite 300
Needham, MA 02494
P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

life science portals

biological therapeutic products
biomarkers & diagnostics
biopharma strategy
bioprocess & manufacturing
chemistry
clinical trials & translational medicine
drug & device safety

drug discovery & development
drug targets
genomics
healthcare
it & informatics
technology & tools for life science
therapeutic indications

chi divisions

conferences
reports
barnett educational services
consulting
publications & eNewsletters
professional services

executive team
testimonials
chi timeline
mailing list
careers

request information
site map
eLearning Calendar
privacy policy